Jiang S, Munker R, Andreeff M
People who stop taking the drug may notice that their appetites return to the levels they experienced before they took it, said Dr
A 2023 analysis of GLP-1 use in oncology patients found no absolute contraindications with endocrine therapies, though individualized monitoring was recommended
Onderzoeksopzet In totaal nemen 264 clinten van Overgewicht Nederland deel aan het onderzoek, dat vijftien maanden zal duren, waarvan mensen twaalf maanden supplementen gebruiken
Novel material-based approaches are also being investigated to advance pulmonary drug delivery, such as thin-film freezing, supercritical fluid technology, nano-in-micro particle systems, crystal-engineered microstructures, and porous drug carriers, all of which aim to improve drug stability, bioavailability, and pulmonary retention [209, 210]